Clinical Trials News

New Blood Clot Device 40% More Effective

4.57143

An experimental device designed to remove blood clots from blocked vessels after a stroke has successfully outperformed a mechanical U.S. Food and Drug Administration-approved device during a trial.

Morning-After Pill Helps Control Uterine Tumors

2.764705

An emergency birth control pill taken after intercourse to prevent pregnancy has been found to prevent something else: intense bleeding caused by fibroids.

Arrhythmia Drug Boasts Lower Brain Bleeding

3.05

Prior to its approval last year, there was much debate about Xarelto (rivaroxaban), an anti-clotting drug designed to prevent stroke among patients with atrial fibrillation, a common heart arrhythmia.

Antipsychotic Drugs May Cause Metabolic Problems

3.1875

Antipsychotic drugs are among the most prescribed drugs in the U.S. Almost all of these drugs are known to possibly cause obesity and diabetes, and, until recently, nobody knew why.

Childhood Infections Linked to Stroke Risk

2.52174

Minor infections during childhood could have more devastating consequences. Common infections could put kids at a higher risk of stroke during the initial month following an infection.

FDA Approves Gleevec for Rare Gastrointestinal Cancer

3.136365

The U.S. Food and Drug Administration granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today’s action also highlights an increase in overall patient survival when the drug is taken for 36 months rather than the standard 12 months of treatment.

Extending Lives of Men With Prostate Cancer

3.186045

Usually, drug companies are the organizations that discover new medicines. It's rare for drugs to come out of academic labs, but that's just what happened with the first medication found to be effective against advanced prostate cancer.

FDA Approved New Type 2 Diabetes Drug

3

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin 

Restraining Brain Cancer Resistance

3.42857

All of the drugs used to treat glioblastoma, an aggressive form of brain cancer, tend to use the same method of attack on a highly resistant point. Traditionally this has not gone very well.

Related Topics:

FDA Approves Advanced Basal Cell Cancer Drug

3.690475

Roche announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

Syndicate content